Hugo Fuentes

8PUBLICATIONS
68CO-AUTHORS
Cell physiologyEpigenetics (incl. genome methylation and epigenomics)Midwifery not elsewhere classifiedPredictive and prognostic markersAboriginal and Torres Strait Islander midwifery and paediatrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
CA 15.3, Metastatic Burden, and Overall Survival in Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer: Real-World Evidence from Peru.

|Sep 23, 2026
Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypes.

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|May 26, 2025
Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM).

|Dec 03, 2024
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Xiaosong Huang, Paul C Lott, Donglei Hu

|Nov 07, 2024
Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.

Guillermo Valencia, Katia Roque, Patricia Rioja

Pageof 2

Frequent Collaborators

7 joint publications

Guillermo Valencia

5 joint publications

Zaida Morante

4 joint publications

Patricia Rioja Viera

4 joint publications

Silvia P Neciosup